During the past decade, Spitalul Clinic Dr. Ioan Cantacuzino conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 6 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 4 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Spitalul Clinic Dr. Ioan Cantacuzino" #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "Perfect Care Distribution" with 3 trials sponsored, "Pierre Fabre Medicament" with 2 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "Cristcot LLC" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Spitalul Clinic Dr. Ioan Cantacuzino" #1 collaborator was "MDX Research" with 3 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator, "Cristcot HCA LLC" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Spitalul Clinic Dr. Ioan Cantacuzino" are "Systemic Lupus Erythematosus" (5 trials), "Rheumatoid Arthritis" (4 trials), "Fibromyalgia Syndrome" (2 trials), "Bacterial Vaginosis" (1 trials) and "Cervical Lesion" (1 trials). Many other conditions were trialed in "Spitalul Clinic Dr. Ioan Cantacuzino" in a lesser frequency.

Most popular intervention types in "Spitalul Clinic Dr. Ioan Cantacuzino" are "Drug" (12 trials), "Device" (3 trials), "Biological" (2 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Baricitinib" (3 trials), "milnacipran" (2 trials), "Adalimumab with methotrexate" (1 trials) and "BMS-986165" (1 trials). Other intervention names were less common.

The vast majority of trials in "Spitalul Clinic Dr. Ioan Cantacuzino" are 14 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Spitalul Clinic Dr. Ioan Cantacuzino". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Spitalul Clinic Dr. Ioan Cantacuzino, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Spitalul Clinic Dr. Ioan Cantacuzino, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".